HCPCS Level IIdrugActive
J9308
Injection, ramucirumab
BETOS: O1D
Effective: 2016-01-01
Description
Injection, ramucirumab, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Cyramza
Manufacturer
Eli Lilly and Company
HCPCS Dosage
5 MG
Billing Units
20.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.